Airsculpt Technologies, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
A Schedule 13G filing reveals significant beneficial ownership of AirSculpt Technologies, Inc. common stock by entities associated with Vesey Street Capital Partners.
NASDAQ
Thrivent Financial for Lutherans and its affiliate TICA have filed an amendment to their Schedule 13G, correcting previous ownership figures and reporting their beneficial ownership as of June 30, 2026.
NASDAQ
Dr. Aaron Rollins has filed a Schedule 13G reporting beneficial ownership of 14,721,062 shares of AirSculpt Technologies, Inc.
NASDAQ
Parian Ultreia LP has filed a Schedule 13G, reporting beneficial ownership of 6,744,000 shares, representing 9.6% of Airsculpt Technologies, Inc.
NASDAQ
Parian Ultreia LP has reported a significant beneficial ownership stake of 9.59% in Airsculpt Technologies, Inc.
NASDAQ
Jorey Chernett has increased beneficial ownership in Airsculpt Technologies, Inc. to 10.79% of common stock.
NASDAQ
SCHEDULE: Airsculpt Investor Exits Entire Stake
SW Investment Management LLC and SWIM Partners, LP report a complete divestment of their beneficial ownership in Airsculpt Technologies, Inc.
NASDAQ
Jorey Chernett has filed an amended Schedule 13G, disclosing beneficial ownership of 9.86% of Airsculpt Technologies, Inc.'s common stock.
NASDAQ
Jorey Chernett has reported beneficial ownership of 5.1% of Airsculpt Technologies, Inc.'s common stock, totaling 3,188,767 shares.
NASDAQ
SCHEDULE: Thrivent Boosts Airsculpt Stake to 8.6%
Thrivent Financial for Lutherans and its affiliate Thrivent Investment Capital Advisors, LLC, have reported beneficial ownership of 8.6% of Airsculpt Technologies, Inc. common stock.
NASDAQ
Vesey Street Capital Partners and its affiliates, including Adam T. Feinstein, have reported a combined beneficial ownership of 48.6% in Airsculpt Technologies, Inc.
NASDAQ
Aaron Rollins, a significant shareholder, has increased his beneficial ownership in AirSculpt Technologies, Inc. to 23.6% of the common stock.
NASDAQ
Dr. Aaron Rollins, an individual, has reported beneficial ownership of 25.0% of Airsculpt Technologies, Inc.'s common stock as of March 31, 2025.
NASDAQ
SCHEDULE 13G/A: Airsculpt Technologies Founder Aaron Rollins Discloses 25.3% Beneficial Ownership Stake
Dr. Aaron Rollins, founder of Airsculpt Technologies, Inc., has reported a beneficial ownership of 25.3% of the company's common stock as of December 31, 2024.